Synopsis
Through its 20-year journey, Indegene has developed deep domain expertise, a robust database, and strong relations with healthcare practitioners, enabling it to provide customised and efficient technology-driven solutions to pharmaceutical companies. With the pandemic fast-tracking tech adoption, Indegene is poised to harness the opportunity of driving the digital transformation of the life-sciences industry globally.
It is well-known that it takes years and billions of dollars for a pharmaceutical company to develop an innovative drug. But commercialisation of drugs is also an investment-heavy affair. For example, selling, informational, and administrative expenses of Pfizer, one of the largest pharma companies in the world, were 27.7% of its revenue of USD42 billion in 2020. These expenses include but are not limited to the company’s spend on marketing and
BY
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
Clean experience with
Minimal AdsComment & Engage with ET Prime community
Exclusive invites to Virtual Events with Industry Leaders
A trusted team of Journalists & Analysts who can best filter signal from noise
For all the latest Technology News Click Here
For the latest news and updates, follow us on Google News.